Wanbury Limited has informed the Exchange regarding a press release dated September 09, 2024, titled "Press Release - Wanbury Limited received a Certificate of Suitability (CEP) forthe launch of its new product, Dextromethorphan (API)".
Wanbury Limited has informed the Exchange regarding a press release dated September 09, 2024, titled "Press Release - Wanbury Limited received a Certificate of Suitability (CEP) forthe launch of its new product, Dextromethorphan (API)".